Shenzhen Xianzhou Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Xianzhou Trading Co., Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 4 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include MERYOSZ, RDSIANE, BVIMEPOS, and HAENPISY. The owner is based in Futian Dist.,Shenzhen.

28H-S1,Fortune Building,No.88,Fuhua 3rd

Road,Gangxia Community,Futian Street

Futian Dist.,Shenzhen 518000 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MERYOSZ
MERYOSZ
Registered 2020
RDSIANE
RDSIANE
Registered 2020
BVIMEPOS
BVIMEPOS
Registered 2020
HAENPISY
HAENPISY
Registered 2020

Trademark Classifications

Shenzhen Xianzhou Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (4 filings)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Shenzhen Xianzhou Trading Co., Ltd. have?

Shenzhen Xianzhou Trading Co., Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Shenzhen Xianzhou Trading Co., Ltd. file in?

Shenzhen Xianzhou Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are Shenzhen Xianzhou Trading Co., Ltd.'s most well-known trademarks?

Shenzhen Xianzhou Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as MERYOSZ, RDSIANE, BVIMEPOS, and HAENPISY. These are among 4 currently registered trademarks in the portfolio.

What is Shenzhen Xianzhou Trading Co., Ltd.'s trademark registration success rate?

Shenzhen Xianzhou Trading Co., Ltd. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.